Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen type IV alpha-4 chain (COL4A4) is a structural protein encoded by the COL4A4 gene, one of six genetically distinct alpha chains forming type IV collagen, the main structural component of basement membranes in various tissues. It forms heterotrimers with other alpha (IV) chains (notably alpha-3 and alpha-5), contributing significantly to the structural scaffolding and integrity of basement membranes, particularly in the kidney glomerulus, inner ear, and eye. Mutations in COL4A4 cause structural network disruption, leading to genetic diseases such as Alport syndrome (characterized by progressive renal failure, hearing loss, and ocular abnormalities) and benign familial hematuria. COL4A4 is not a classic therapeutic drug target such as a receptor, enzyme, or transporter, but its function as a core basement membrane protein means that its genetic variants serve as important disease biomarkers and diagnostic markers in hereditary kidney and basement membrane disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen type IV alpha-4 chain (COL4A4).